Is Blue Water Petroleum Corp going to be the tech company that finally launches large-scale graphene commercialization?
TSI Exclusive
Looking For The Perfect Inflation Hedge? Try This Company
Inflation is rapidly eroding our purchasing power and consuming our wealth. Here is a powerful antidote for investors.
Inflation Capitulation Signals Dollar’s Demise, Gold’s Rise
Central banks aren't "accepting" higher levels of price inflation. They are being run over by it.
U.S. Hyperinflation Unmasked: BoA Sees ‘Transitory Hyper-inflation’ Coming
Warning #1: Bank of America sees transitory hyperinflation coming. Warning #2: there is nothing "transitory" about this.
Investors Forget About Gold At WORST Possible Time
As more and more traders experience "inflation fears", investors have FORGOTTEN the ultimate insurance for inflation: gold
Which Equities Can Best Survive Hyperinflation?
U.S. hyperinflation is coming. This is the best strategy to prepare.
Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer
A major IPO can be expected to attract a lot of new attention (and capital) to the psychedelic drug industry.
The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research
The Psychedelics Revolution. One part changing social attitudes. One part medical necessity. One part hard economics.
Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD
Eleusis Therapeutics is a private psychedelics company that is turning a lot of heads with its research on micro-doses of LSD as a treatment for Alzheimer's.
What Does Field Trip Psychedelics Offer Investors?
Field Trip Psychedelics has just announced a letter of intent to go public via RTO.
Canadians More Receptive To Use Of Psilocybin For The Terminally Ill: New Poll
Canadians are rapidly warming up to the idea of using psilocybin to reduce distress among the terminally ill.
ATAI Life Sciences Forges Premier Psychedelics R&D Platform
ATAI Life Sciences is preparing to add three new drug development partners as it builds the premier R&D platform in the psychedelics space.
What A Trip! Psychedelics Stocks Flying High
Several psychedelics companies have generated impressive returns for investors in recent weeks.
Cannabis Sales Soar 48% In 2019, 2020 Looking Even Stronger
In a "bad" year for the emerging cannabis industry, global cannabis sales rose by 48% in 2019. That's not bad.
Is CBD ‘Harmful’ to Our Liver? No.
The U.S. Food and Drug Administration is claiming that CBD poses significant risks to the human liver. Nonsense.